✦ LIBER ✦

Thalidomide plus dexamethasone for newly diagnosed myeloma

✍ Scribed by Heather Lindsey

Book ID: 117782751
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 51 KB
Volume: 3
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(02)00943-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vincristine, doxorubicin, and dexamethas

Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?

✍ Víctor Hugo Jimenez-Zepeda; Virginia Jeanet Domínguez-Martínez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

A383 Bortezomib plus Thalidomide in Newl

A383 Bortezomib plus Thalidomide in Newly Diagnosed Myeloma

✍ Chen, S; Wang, L; Jiang, B; Qiu, L; Li, Y; Zhong, Y; Gao, W 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Bortezomib Plus Thalidomide for Newly Di

Bortezomib Plus Thalidomide for Newly Diagnosed Multiple Myeloma in China

✍ Shi-Lun Chen; Bin Jiang; Lu-Gui Qiu; Li Yu; Yu-Ping Zhong; Wen Gao 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 126 KB

Tumor lysis syndrome following thalidomi

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

✍ Alissa Huston; Jason Brown; G. David Roodman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A174 Thalidomide/Dexamethasone Induction

A174 Thalidomide/Dexamethasone Induction Therapy in Newly Diagnosed Myeloma Patients with Renal Failure

✍ Tosi, P; Tacchetti, P; Zamagni, E; Tacchetti, P; Ceccolini, M; Perrone, G; Briol 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience

✍ Weiyan Zheng; Guoqing Wei; Xiujin Ye; Jingsong He; Li Li; Wenjun Wu; Jimin Shi; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 245 KB

## Objective: Bortezomib-dexamethasone-thalidomide has been reported to be effective in newly-diagnosed multiple myeloma (mm) with an overall response rate of 92% and a cr rate of 18% (alexanian et al, hematology 2007;12(3):235-9), but this regimen has not been tested in the chinese patients. we re